As the combination of TNF blockade and recombinant IL-10 had previously exhibited encouraging results in the collagen-induced arthritis model [4], we became interested in studying whether a combination with F8-IL10 would also exhibit a potent inhibition of disease progression. Here, TNF is linked to arthritic joint disease.